Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Alexis Coulis; Shir Levanon; Gurshaun Randhawa; Yevgeniy Brailovsky; Farhan Raza; Estefania Oliveros

doi:10.3389/fspor.2024.1477562

Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Front Sports Act Living. 2024 Nov 20:6:1477562. doi: 10.3389/fspor.2024.1477562. eCollection 2024.

Authors

Alexis Coulis¹, Shir Levanon¹, Gurshaun Randhawa¹, Yevgeniy Brailovsky², Farhan Raza³, Estefania Oliveros¹

Affiliations

¹ Temple Heart and Vascular Institute, Temple University Hospital, Philadelphia, PA, United States.
² Jefferson Heart Institute, Thomas Jefferson University, Philadelphia, PA, United States.
³ Department of Medicine-Cardiovascular Division, University of Wisconsin Hospital, Madison, WI, United States.

Abstract

Cardiopulmonary exercise testing allows for a comprehensive assessment of the mechanism of exercise limitation in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Competitive pathophysiologic mechanisms may affect the clinical interpretation of cardiopulmonary disease as they relate to dyspnea, leg fatigue, and exercise intolerance.

Keywords: cardiopulmonary exercise testing; chronic thromboembolic pulmonary disease; chronic thromboembolic pulmonary hypertension; pulmonary embolism; pulmonary hypertension.

Publication types

Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported from the AHA Career Grant 23CDA1057697 (FR) and NIH/NCATS ICTR KL2TR002374-07 (FR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the AHA or NIH.